Comparison of In-Hospital Major Adverse Cardiovascular Events in Patients with Acute Myocardial Infarction Treated with Ticagrelor or Clopidogrel in the Emergency Department: A Propensity Score Matched Retrospective Cohort Study.
| Autor: | Huang, Po-Yao, Shih, Hong-Mo, Huang, Szu-Wei, Pan, Yan-Cheng, Huang, Fen-Wei, Chen, Wei-Kung, Yu, Shao-Hua |
|---|---|
| Předmět: |
STATISTICS
HOSPITAL emergency services CONFIDENCE intervals COMBINATION drug therapy MAJOR adverse cardiovascular events MULTIVARIATE analysis MYOCARDIAL infarction RETROSPECTIVE studies CLOPIDOGREL T-test (Statistics) PLATELET aggregation inhibitors RESEARCH funding DESCRIPTIVE statistics CHI-squared test DATA analysis software ODDS ratio LOGISTIC regression analysis ACUTE diseases LONGITUDINAL method DISEASE risk factors |
| Zdroj: | Healthcare (2227-9032); Aug2023, Vol. 11 Issue 16, p2246, 11p |
| Abstrakt: | Background: Dual antiplatelet therapy (DAPT) is a standard treatment option for acute myocardial infarction (AMI). The difference between the efficacy of ticagrelor and clopidogrel in the emergency department (ED) before percutaneous coronary intervention (PCI) remains unknown. The present study compared the in-hospital major adverse cardiovascular event (MACE) rates between patients with AMI treated with clopidogrel and those treated with ticagrelor in the ED before PCI. Methods: We retrospectively collected the data of patients diagnosed as having AMI in the ED. Patients were only included if they had successfully received complete DAPT with aspirin and ticagrelor/clopidogrel in the ED and had undergone PCI. The patients were divided into two groups according to their DAPT regimen. The primary outcome was the rate of in-hospital MACEs. The secondary outcomes included an unexpected return to the ED within 72 h, readmission within 14 d, and revascularization. Results: A total of 1836 patients were enrolled. Patients in the ticagrelor group had a lower in-hospital MACE rate (3.01% versus 7.51%, p < 0.001) and in-hospital mortality rate (2.15% versus 5.70%, p < 0.001) than those in the clopidogrel group. Multivariate logistic regression analysis revealed ticagrelor was independently associated with a lower risk of in-hospital MACEs (odds ratio [OR]: 0.53, 95% CI: 0.32–0.88, p = 0.013). After propensity score matching, the risk of in-hospital MACEs remained significantly lower in the ticagrelor group (OR 0.42, 95% CI: 0.21–0.85, p = 0.016). Conclusion: DAPT with ticagrelor and aspirin in the ED before PCI is associated with a lower in-hospital MACE rate among patients with AMI. [ABSTRACT FROM AUTHOR] |
| Databáze: | Complementary Index |
| Externí odkaz: |
|